Skip to main content
SpringerLink
Log in

Paclitaxel/pexidartinib

Vanishing bile duct syndrome and drug-induced liver injury: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Piawah S, et al. A case report of vanishing bile duct syndrome after exposure to pexidartinib (PLX3397) and paclitaxel. npj Breast Cancer 5: No. 1, 14 Jun 2019. Available from: URL: http://doi.org/10.1038/s41523-019-0112-z

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Paclitaxel/pexidartinib. Reactions Weekly 1815, 266 (2020). https://doi.org/10.1007/s40278-020-81592-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-81592-z

Search

Navigation